MAZZINI, LETIZIA
 Distribuzione geografica
Continente #
NA - Nord America 5.744
EU - Europa 4.995
AS - Asia 3.492
SA - Sud America 532
Continente sconosciuto - Info sul continente non disponibili 267
AF - Africa 190
OC - Oceania 4
Totale 15.224
Nazione #
US - Stati Uniti d'America 5.482
RU - Federazione Russa 1.333
SG - Singapore 1.240
IE - Irlanda 856
IT - Italia 854
CN - Cina 724
DE - Germania 496
HK - Hong Kong 457
VN - Vietnam 431
BR - Brasile 396
SE - Svezia 370
FR - Francia 231
UA - Ucraina 217
BD - Bangladesh 164
GB - Regno Unito 163
FI - Finlandia 137
CA - Canada 130
BJ - Benin 101
KR - Corea 98
IN - India 97
MX - Messico 49
NL - Olanda 49
PL - Polonia 49
JP - Giappone 48
AR - Argentina 45
AT - Austria 41
TR - Turchia 39
ID - Indonesia 38
ZA - Sudafrica 38
EE - Estonia 31
CZ - Repubblica Ceca 29
IQ - Iraq 28
ES - Italia 27
IR - Iran 27
BE - Belgio 26
CO - Colombia 20
EC - Ecuador 19
DK - Danimarca 18
LT - Lituania 17
CL - Cile 15
JM - Giamaica 15
JO - Giordania 13
RO - Romania 13
DZ - Algeria 12
PY - Paraguay 12
AE - Emirati Arabi Uniti 11
CR - Costa Rica 10
DO - Repubblica Dominicana 9
VE - Venezuela 9
MA - Marocco 8
PH - Filippine 8
PK - Pakistan 8
SV - El Salvador 8
TN - Tunisia 8
CH - Svizzera 7
HN - Honduras 7
PE - Perù 7
SA - Arabia Saudita 7
TH - Thailandia 7
MY - Malesia 6
UZ - Uzbekistan 6
GR - Grecia 5
GT - Guatemala 5
KE - Kenya 5
NI - Nicaragua 5
PR - Porto Rico 5
RS - Serbia 5
TT - Trinidad e Tobago 5
AU - Australia 4
AZ - Azerbaigian 4
BO - Bolivia 4
IL - Israele 4
LV - Lettonia 4
NP - Nepal 4
PA - Panama 4
PT - Portogallo 4
UY - Uruguay 4
BB - Barbados 3
CW - ???statistics.table.value.countryCode.CW??? 3
EG - Egitto 3
EU - Europa 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
AO - Angola 2
BG - Bulgaria 2
BS - Bahamas 2
BW - Botswana 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
GD - Grenada 2
GE - Georgia 2
HU - Ungheria 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
NG - Nigeria 2
SI - Slovenia 2
SN - Senegal 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 14.944
Città #
Dublin 851
San Jose 582
Hong Kong 452
Council Bluffs 442
Singapore 437
Ashburn 401
Jacksonville 351
Beijing 263
Los Angeles 181
Columbus 168
Moscow 160
Dearborn 157
Ho Chi Minh City 140
Lauterbourg 129
Chandler 123
Cotonou 101
New York 100
Seoul 93
Phoenix 91
Santa Clara 90
Buffalo 89
Novara 86
Dallas 83
Hanoi 78
Munich 76
Princeton 73
Lawrence 72
Wilmington 71
Rome 63
Piemonte 61
Milan 57
Orem 55
Turin 55
San Mateo 50
Ann Arbor 49
Bremen 48
Houston 46
São Paulo 45
Helsinki 43
Montreal 41
Boardman 37
Denver 37
Brooklyn 36
Frankfurt am Main 35
Chicago 34
Mülheim 34
Warsaw 34
Tokyo 32
Atlanta 31
Carrboro 31
Falkenstein 31
Nuremberg 29
Toronto 29
Boston 27
Schaumburg 25
Brno 24
London 24
Mexico City 24
Stockholm 24
Strasbourg 24
Chennai 23
Johannesburg 23
Redondo Beach 23
San Francisco 23
The Dalles 23
Philadelphia 22
Vienna 21
Amsterdam 19
Olathe 19
Brussels 18
Tianjin 18
Andover 17
Ankara 17
Nanjing 17
North Bergen 17
Rio de Janeiro 16
Seattle 16
Jakarta 15
Manchester 15
Vercelli 15
Woodbridge 15
Da Nang 14
Guangzhou 14
Haiphong 14
Hải Dương 14
Monmouth Junction 14
Turku 14
Hangzhou 13
Poplar 13
Zanjan 13
Amman 12
Hillsboro 12
Queens 12
Kunming 11
Tornaco 11
Baghdad 10
Biên Hòa 10
Las Vegas 10
Quận Bình Thạnh 10
St Louis 10
Totale 7.778
Nome #
Acetyl-L-carnitine and Amyotrophic Lateral Sclerosis: current evidence and potential use. 276
Retrospective observational study on the use of acetyl-L-carnitine in ALS 201
Advances in stem cell therapy for amyotrophic lateral sclerosis 190
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 189
Analysis of the GCG Repeat Length in NIPA1 Gene in C9orf72-mediated ALS in a Large Italian ALS Cohort 176
ALS Phenotype Is Influenced by Age, Sex, and Genetics: A Population-Based Study 171
Amyotrophic Lateral Sclerosis Outcome Measures and the Role of Albumin and Creatinine: A Population-Based Study. 168
The Epidemiology of Primary Lateral Sclerosis: Results from a Population‐Based Cohort 158
Association of a locus in the CAMTA1 gene with survival in patients with sporadic amyotrophic lateral sclerosis 153
The First Case of the TARDBP p.G294V Mutation in a Homozygous State: Is a Single Pathogenic Allele Sufficient to Cause ALS? 150
Human neural stem cell transplantation in ALS: initial results from a phase I trial. 149
Expanding the genetic spectrum of primary familial brain calcification due to SLC2OA2 mutations: a case series 146
Characterization of the c9orf72 GC-rich low complexity sequence in two cohorts of Italian and Turkish ALS cases 143
A case of Progressive Non-Fluent Aphasia as onset of Amyotrophic Lateral Sclerosis with FrontoTemporal Dementia 142
Coeliac disease mimicking Amyotrophic Lateral Sclerosis. 140
ATXN2 polyQ intermediate repeats are a modifier of ALS survival. 138
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways 138
Ptosis and bulbar onset: an unusual phenotype of familial ALS? 137
Lower Circulating Gas6 Levels Are Associated with Bulbar Phenotype and Faster Disease Progression in Amyotrophic Lateral Sclerosis Patients 136
Analysis of the KIFAP3 gene in amyotrophic lateral sclerosis: a multicenter survival study 136
Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials? 136
Effects of Acetyl-L-Carnitine on Oxidative Stress in Amyotrophic Lateral Sclerosis Patients: Evaluation on Plasma Markers and Members of the Neurovascular Unit 133
Study protocol on the safety and feasibility of a normocaloric ketogenic diet in people with amyotrophic lateral sclerosis 133
Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants 132
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis 132
A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis 131
Genetic correlation between amyotrophic lateral sclerosis and schizophrenia 129
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study 129
The Potential Role of Peripheral Oxidative Stress on the Neurovascular Unit in Amyotrophic Lateral Sclerosis Pathogenesis: A Preliminary Report from Human and In Vitro Evaluations 127
A novel peripherin gene (PRPH) mutation identified in one sporadic amyotrophic lateral sclerosis patient 125
The prevention of falls in patients with Parkinson's disease with in-home monitoring using a wearable system: a pilot study protocol 123
Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis 123
Potential Role of Gut Microbiota in ALS Pathogenesis and Possible Novel Therapeutic Strategies 123
The multistep hypothesis of ALS revisited: The role of genetic mutations 123
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial 122
Detection of white matter ultrastructural changes for amyotrophic lateral sclerosis characterization: A diagnostic study from DTI-derived data 121
Novel optineurin mutations in patients with familial and sporadic amyotrophic lateral sclerosis 120
Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers 118
Phosphatemia is an Independent Prognostic Factor in Amyotrophic Lateral Sclerosis 117
Amyotrophic lateral sclerosis regional progression intervals change according to time of involvement of different body regions 116
Extensive genetics of ALS: a population-based study in Italy. 115
Long-term survival of participants in a phase II randomized trial of RNS60 in amyotrophic lateral sclerosis 114
Cognitive impairment across ALS clinical stages in a population-based cohort 114
New Insights into the Relationship between Nutrition and Neuroinflammation in Alzheimer's Disease: Preventive and Therapeutic Perspectives 113
Critical illness neuro-myopathy (CINM) and focal amyotrophy in intensive care unit (ICU) patients with SARS-CoV-2: a case series 112
Neurological emergency at the COVID-19 pandemic: report from a referral hospital in Eastern Piedmont, Italy 112
Adopting Assistive Technologies in Healthcare Processes: A Chatbot for Patients with Amyotrophic Lateral Sclerosis 111
Coupling motor evoked potentials and brain [18F]FDG-PET in Amyotrophic Lateral Sclerosis: preliminary findings on disease severity 110
Exploring the phenotype of Italian patients with ALS with intermediate ATXN2 polyQ repeats 110
TUBA4A gene analysis in sporadic amyotrophic lateral sclerosis: identification of novel mutations 110
Circulating GLAST+ EVs are increased in amyotrophic lateral sclerosis 109
The Need for Biomarkers in the ALS-FTD Spectrum: A Clinical Point of View on the Role of Proteomics 106
Autologous Stem Cells Transplantation in Amyotrophic Lateral Sclerosis: A Phase I Clinical Trial 106
Potential role of vitamin D levels in amyotrophic lateral sclerosis cognitive impairment 105
null 105
Depression and risk of Cognitive Dysfunctions in Amyotrophic Lateral Sclerosis 105
Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study 104
Association of Copresence of Pathogenic Variants Related to Amyotrophic Lateral Sclerosis and Prognosis 104
Predicting functional impairment trajectories in amyotrophic lateral sclerosis: a probabilistic, multifactorial model of disease progression 103
Functional status and oral health in patients with amyotrophic lateral sclerosis: A cross-sectional study 102
A rare case of conjugal amyotrophic lateral sclerosis. 102
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: A population-based study 101
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 100
Accelerated early progression of amyotrophic lateral sclerosis over the covid-19 pandemic 100
Transplantation of mesenchymal stem cells in ALS. 99
Chitotriosidase and lysosomal enzymes as potential biomarkers of disease progression in amyotrophic lateral sclerosis: a survey clinic-based study. 99
Challenging the boundaries: c9orf72 mutation presenting as Alzheimer's disease 98
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology 98
ATXN-2 CAG repeat expansions are interrupted in ALS patients 98
Rapamycin treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial) 96
NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. 95
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 95
Current status and new avenues of stem cell-based preclinical and therapeutic approaches in amyotrophic lateral sclerosis 94
Identification of Transcriptomic Differences in Induced Pluripotent Stem Cells and Neural Progenitors from Amyotrophic Lateral Sclerosis Patients Carrying Different Mutations: A Pilot Study 94
C9ORF72 repeat expansion in a large Italian ALS cohort: evidence of a founder effect. 93
Telehealth Approach For Amyotrophic Lateral Sclerosis Patients: The experience during COVID-19 pandemic 93
Authors' response to a letter from Dr. Esquinas. 92
Generation of an induced pluripotent stem cell line, CSSi011-A (6534), from an Amyotrophic lateral sclerosis patient with heterozygous L145F mutation in SOD1 gene 91
Exploring the phenotypic fingerprints of ANXA11 variants in ALS: a population-based study in an European cohort 91
Profiling cognition and brain metabolism in amyotrophic lateral sclerosis and frontotemporal dementia 91
Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact 90
Withdrawal of mechanical ventilation in amyotrophic lateral sclerosis patients: a multicenter Italian survey 90
Novel Therapeutic Strategies in Alzheimer's Disease: Pitfalls and Challenges of Anti-Amyloid Therapies and Beyond 90
Plateaus in amyotrophic lateral sclerosis progression: results from a population-based cohort 90
Characterization of the p.L145F and p.S135N Mutations in SOD1: Impact on the Metabolism of Fibroblasts Derived from Amyotrophic Lateral Sclerosis Patients 89
Shotgun Proteomics Links Proteoglycan-4+ Extracellular Vesicles to Cognitive Protection in Amyotrophic Lateral Sclerosis 89
High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis 89
Variations in the coding and regulatory sequences of the angiogenin (ANG) gene are not associated to ALS (amyotrophic lateral sclerosis) in the Italian population 89
Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses 87
Effect of mesenchymal stromal cell transplantation on long-term survival in amyotrophic lateral sclerosis 87
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis 87
A Telehealth Intervention for Nutritional Counseling in Amyotrophic Lateral Sclerosis Patients 86
Mutational analysis of VCP gene in familial amyotrophic lateral sclerosis 86
Mutations of FUS gene in sporadic amyotrophic lateral sclerosis 86
Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome 85
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis 85
Respiratory support in a population-based ALS cohort: Demographic, timing and survival determinants 84
No association of DPP6 with amyotrophic lateral sclerosis in an Italian population 84
SOD1 gene mutations in Italian patients with Sporadic Amyotrophic Lateral Sclerosis (ALS) 84
Screening of the PFN1 gene in sporadic amyotrophic lateral sclerosis and in frontotemporal dementia. 83
Totale 11.580
Categoria #
all - tutte 73.051
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.051


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022494 0 0 0 70 27 10 19 14 46 18 152 138
2022/20231.702 87 84 61 25 112 121 53 81 927 21 92 38
2023/2024644 59 41 78 33 101 20 94 9 11 7 60 131
2024/20252.099 45 44 122 44 39 235 136 212 405 207 171 439
2025/20266.485 327 255 392 844 700 462 841 1.010 419 490 452 293
2026/20272.172 355 630 552 635 0 0 0 0 0 0 0 0
Totale 15.224